Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Many Antidepressant Users Have No History of Mental Disorders

By HospiMedica International staff writers
Posted on 10 Nov 2015
A new study reveals that a majority of the people who use antidepressants in the United States never met the criteria for major depressive disorder (MDD).

Researchers at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) used data from the Baltimore (MD, USA) Epidemiologic Catchment Area (ECA) study between 1981 and 2005 to examine the prevalence of mental disorders, as assessed prospectively over multiple interviews with 1,071 individuals who reported current antidepressant use. More...
Lifetime prevalence of common mood and anxiety disorders were evaluated based on four interviews, as well as other factors associated with current antidepressant use.

The results showed that 69% of the patients never met the criteria for MDD; 38% never met criteria for MDD, obsessive-compulsive disorder, panic disorder, social phobia, or generalized anxiety disorder throughout their lifetime. Female gender, Caucasian ethnicity, recent or current physical problems—such as loss of bladder control, hypertension, and back pain—and recent mental health facility visits were associated with antidepressant use, in addition to mental disorders. The study was published in the October 2015 issue of the Journal of Clinical Psychiatry.

“We all experience periods of stress, periods of sadness, and periods of self-doubt; these don’t make us mentally ill, they define us as human,” concluded lead author Yoichiro Takayanagi, MD, PhD, and colleagues. “Many individuals who are prescribed and use antidepressant medications may not have met criteria for mental disorders. Our data indicate that antidepressants are commonly used in the absence of clear evidence-based indications.”

“With non-specialists playing a growing role in the pharmacological treatment of common mental disorders, practice patterns of these providers are becoming increasingly relevant for mental health policy,” said senior author Ramin Mojtabai, MD, PhD, MPH, commenting on an earlier study. “To the extent that antidepressants are being prescribed for uses not supported by clinical evidence, there may be a need to improve providers’ prescribing practices, revamp drug formularies, or undertake broad reforms of the health care system that will increase communication between primary care providers and mental health specialists.”

Related Links:

Johns Hopkins Bloomberg School of Public Health



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.